Association of the mutation for the human carboxypeptidase E gene exon 4 with the severity of coronary artery atherosclerosis
Authors:
- 16 December 2007
- journal article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 36 (2) , 245-254
Abstract
Objective: To test the hypothesis that the identification of mutation in the carboxypeptidase E (CPE) gene which leads to marked hyperproinsulinaemia is consistent with a possible role for mutations in CPE in the development of coronary atherosclerosis. Methods: The study subjects consisted of 1084 consecutive patients (812 males and 272 females) who will undergo coronary angiography. The severity of coronary atherosclerosis was defined by the Gensini’s score system. The proinsulin level was measured using highly sensitive two-site sandwich ELISA methods. Screening for mutations of the 4th exon and exon-intron junctional region of the CPE gene was performed by polymerase chain reaction followed by bidirectional sequencing. Results: Sequencing of the CPE gene exon 4 in 1084 consecutive patients revealed 2 genetic variants, the G–to-A substitution at nucleotide 2855 in exon 4 (synonymous mutation) and A-to-G substitution at nucleotide 2925 in intron 4. Although the proinsulin level was not influenced by the presence of the two point mutation, the Gensini score was significantly influenced by the presence of the A2925G mutant (P = 0.023). Furthermore, we found a higher prevalence of subjects with the A2925G heterozygous mutant among higher Gensini score subjects than it among lower Gensini score subjects, and this difference reached statistical significance (P = 0.006, OR 1.465, 95%CI 1.116–1.924). In addition, the frequency distribution of the G2855A mutant was differed in the higher Gensini score subjects than it in the lower Gensini score subjects belonging to high-risk category as smokers, and the statistical significance was reached (P = 0.043, OR 2.075, 95%CI 1.024–4.207). Conclusions: In the present study, the severity of the coronary atherosclerosis estimated by Gensini score was significantly influenced by the presence of the A2925G mutant and G2855A mutant of the CPE gene, and the exactly mechanism underlying the association needs further study.Keywords
This publication has 26 references indexed in Scilit:
- Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studiesEuropean Heart Journal, 2007
- Proinsulin Is an Independent Predictor of Coronary Heart DiseaseCirculation, 2002
- Missense polymorphism in the human carboxypeptidase E gene alters enzymatic activityHuman Mutation, 2001
- The Sequence of the Human GenomeScience, 2001
- Patterns of Genetic Variation in Mendelian and Complex TraitsAnnual Review of Genomics and Human Genetics, 2000
- RNA secondary structure and compensatory evolution.Genes & Genetic Systems, 1999
- Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection.Journal of Clinical Investigation, 1996
- Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activityNature Genetics, 1995
- Insulin Deficiency and Increased Plasma Concentration of Intact and 32/33 Split Proinsulin in Subjects with Impaired Glucose ToleranceDiabetic Medicine, 1993
- A more meaningful scoring system for determining the severity of coronary heart diseaseThe American Journal of Cardiology, 1983